Related Experiment Videos
CD4+CD28-T cells are expanded in sarcoidosis
Scott D Roberts1, Lisa L Kohli, Karen L Wood
1Indiana University School of Medicine, Indianapolis, Indiana, USA.
Summary
CD4+CD28- T cells are elevated in the blood and lungs of sarcoidosis patients, potentially driving inflammation. However, these cells do not significantly produce key inflammatory cytokines like IFN-gamma or TNF-alpha.
Area of Science:
- Immunology
- Cell Biology
- Pulmonary Medicine
Background:
- CD4+CD28- T cells, a subset lacking the costimulatory molecule CD28, are implicated in inflammatory diseases.
- Previous research has not extensively investigated CD4+CD28- T cells in chronic sarcoidosis patients.
Purpose of the Study:
- To characterize the CD4+CD28- T cell population in patients with chronic sarcoidosis.
- To investigate the role of these cells in active sarcoidosis disease.
Main Methods:
- Studied 17 chronic sarcoidosis patients and 15 healthy blood donors.
- Analyzed peripheral blood and bronchoalveolar lavage (BAL) cells using flow cytometry.
- Measured IFN-gamma levels via ELISA and cytometric bead array.
Main Results:
- Sarcoidosis patients showed a higher proportion of CD4+CD28- T cells in peripheral blood compared to controls.
- Active sarcoidosis patients had a greater percentage of CD4+CD28- T cells in BAL fluid versus peripheral blood.
- Elevated IFN-gamma levels were observed in sarcoidosis patients' plasma and BAL fluid.
Conclusions:
- Increased CD4+CD28- T cells are present in the peripheral blood and lungs of sarcoidosis patients requiring treatment.
- These cells may contribute to sarcoidosis-related inflammation.
- CD4+CD28- T cells are not the primary producers of IFN-gamma or TNF-alpha in sarcoidosis.